Golden
Eloxx Pharmaceuticals

Eloxx Pharmaceuticals

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

June 2017

Eloxx Pharmaceuticals raises a $5,000,000 series C round from GF Securities, Pontifax Venture Capital, Quark Venture Capital, DSC Investments, OPKO Health, Korea Investment Partners and Phillip Frost.

Funding rounds

People

Name
Role
LinkedIn
+ Add new row

Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row